| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 32.028 | 33.539 | 36.185 | 44.376 | 55.132 | 55.013 | 70.296 | 76.095 | 86.510 | 96.391 |
| Total Income - EUR | 33.470 | 34.730 | 37.230 | 47.369 | 55.734 | 56.763 | 70.984 | 76.998 | 87.282 | 109.255 |
| Total Expenses - EUR | 18.809 | 13.557 | 15.740 | 22.304 | 31.673 | 37.374 | 32.952 | 32.858 | 24.360 | 34.861 |
| Gross Profit/Loss - EUR | 14.661 | 21.173 | 21.490 | 25.065 | 24.061 | 19.388 | 38.032 | 44.140 | 62.922 | 74.393 |
| Net Profit/Loss - EUR | 13.657 | 20.479 | 21.117 | 24.591 | 23.503 | 18.870 | 37.323 | 43.370 | 62.067 | 71.181 |
| Employees | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 3 |
Check the financial reports for the company - Danamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 17.879 | 12.889 | 9.799 | 3.692 | 0 | 0 | 0 |
| Current Assets | 15.521 | 21.854 | 22.464 | 7.975 | 12.131 | 11.708 | 35.637 | 44.686 | 63.665 | 76.442 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 11.415 | 16.243 | 20.687 | 6.008 | 8.709 | 3.566 | 29.943 | 37.166 | 46.438 | 58.050 |
| Cash | 4.106 | 5.611 | 1.777 | 1.966 | 3.422 | 8.142 | 5.694 | 7.520 | 17.228 | 18.392 |
| Shareholders Funds | 14.271 | 20.932 | 21.170 | 24.643 | 23.554 | 18.919 | 37.371 | 43.419 | 62.115 | 71.230 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.250 | 922 | 1.380 | 1.424 | 1.596 | 2.588 | 2.198 | 1.507 | 1.722 | 5.369 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Danamed S.r.l.